Kelly Mai1, Jeanie Jy Chui2, Nick Di Girolamo1, Peter J McCluskey3, Denis Wakefield4. 1. Inflammation and Infection Research Centre, Department of Pathology, School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia. 2. Inflammation and Infection Research Centre, Department of Pathology, School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia ; Department of Ophthalmology, Prince of Wales Hospital, Randwick, NSW, Australia. 3. Save Sight Institute, Sydney Eye Hospital, University of Sydney, Sydney, Australia. 4. Inflammation and Infection Research Centre, Department of Pathology, School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia ; UNSW Medicine, University of New South Wales, Sydney, Australia.
Abstract
BACKGROUND: Toll-like receptor (TLR) activation is hypothesized to contribute to inflammatory eye disease including uveitis, yet the distribution pattern of TLRs in human uveal tissues remains poorly described. The purpose of this study was to investigate the expression profile of TLRs in human iris pigment epithelial cells (IPE) at the gene and protein level and examine the effect of pathogen-associated molecular patterns (PAMPs), such as Pam3CSK4.3HCl, Poly(I:C), lipopolysaccharides (LPS from E. coli serotype O111:B4), Flagellin, MALP-2 (macrophage activating lipopeptide-2), Poly(U) and CpGODN2395 on the production of inflammatory mediators including interleukin-8 (IL-8) and monocyte chemotactic protein 1 (MCP-1) from human IPE and retinal pigment epithelial cells (RPE). METHODS: RT-PCR and Western blotting was employed to investigate the expression of TLRs 1-10 in primary IPE and RPE. Secretion of IL-8 or MCP-1 following treatment with PAMPs was measured by ELISA. The role of TLR2, TLR3 and TLR4 in mediating an inflammatory response was investigated using pharmacological TLR inhibitors. RESULTS: IPE and RPE expressed transcripts for TLR1-6 and 8-10; and proteins for TLR1-6 and 9. IPE secreted IL-8 or MCP-1 in response to Pam3CSK4.3HCl, Poly(I:C), LPS and MALP-2, whereas RPE produced IL-8 only after Poly(I:C), LPS or MALP-2 treatment. TLR inhibitors (OxPAPC, CI-095 and chloroquine) blocked IL-8 secretion in Poly(I:C), LPS or MALP-2-treated IPE and RPE. CONCLUSIONS: Ocular pigment epithelial cells respond to PAMPs through activation of TLRs, particularly TLR2, TLR3 and TLR4. Expression of TLRs in human IPE cells provides a basis for responses to many ocular pathogens and their activation may be involved in the pathogenesis of ocular inflammation.
BACKGROUND: Toll-like receptor (TLR) activation is hypothesized to contribute to inflammatory eye disease including uveitis, yet the distribution pattern of TLRs in human uveal tissues remains poorly described. The purpose of this study was to investigate the expression profile of TLRs in human iris pigment epithelial cells (IPE) at the gene and protein level and examine the effect of pathogen-associated molecular patterns (PAMPs), such as Pam3CSK4.3HCl, Poly(I:C), lipopolysaccharides (LPS from E. coli serotype O111:B4), Flagellin, MALP-2 (macrophage activating lipopeptide-2), Poly(U) and CpGODN2395 on the production of inflammatory mediators including interleukin-8 (IL-8) and monocyte chemotactic protein 1 (MCP-1) from humanIPE and retinal pigment epithelial cells (RPE). METHODS: RT-PCR and Western blotting was employed to investigate the expression of TLRs 1-10 in primary IPE and RPE. Secretion of IL-8 or MCP-1 following treatment with PAMPs was measured by ELISA. The role of TLR2, TLR3 and TLR4 in mediating an inflammatory response was investigated using pharmacological TLR inhibitors. RESULTS:IPE and RPE expressed transcripts for TLR1-6 and 8-10; and proteins for TLR1-6 and 9. IPE secreted IL-8 or MCP-1 in response to Pam3CSK4.3HCl, Poly(I:C), LPS and MALP-2, whereas RPE produced IL-8 only after Poly(I:C), LPS or MALP-2 treatment. TLR inhibitors (OxPAPC, CI-095 and chloroquine) blocked IL-8 secretion in Poly(I:C), LPS or MALP-2-treated IPE and RPE. CONCLUSIONS: Ocular pigment epithelial cells respond to PAMPs through activation of TLRs, particularly TLR2, TLR3 and TLR4. Expression of TLRs in humanIPE cells provides a basis for responses to many ocular pathogens and their activation may be involved in the pathogenesis of ocular inflammation.
Authors: P I Song; T A Abraham; Y Park; A S Zivony; B Harten; H F Edelhauser; S L Ward; C A Armstrong; J C Ansel Journal: Invest Ophthalmol Vis Sci Date: 2001-11 Impact factor: 4.799
Authors: Beatriz E Brito; David O Zamora; Robert A Bonnah; Yuzhen Pan; Stephen R Planck; James T Rosenbaum Journal: Exp Eye Res Date: 2004-08 Impact factor: 3.467
Authors: Mark Rutz; Jochen Metzger; Tanja Gellert; Peter Luppa; Grayson B Lipford; Hermann Wagner; Stefan Bauer Journal: Eur J Immunol Date: 2004-09 Impact factor: 5.532
Authors: Vadim V Sumbayev; Inna Yasinska; Abraham E Oniku; Claire L Streatfield; Bernhard F Gibbs Journal: PLoS One Date: 2012-03-28 Impact factor: 3.240
Authors: Brenda Fernanda Moreira Castro; Carolina Nunes da Silva; Lídia Pereira Barbosa Cordeiro; Sarah Pereira de Freitas Cenachi; Daniel Vitor Vasconcelos-Santos; Renes Resende Machado; Luiz Guilherme Dias Heneine; Luciana Maria Silva; Armando Silva-Cunha; Silvia Ligório Fialho Journal: Curr Res Pharmacol Drug Discov Date: 2022-05-11
Authors: Feargal J Ryan; Jillian M Carr; João M Furtado; Yuefang Ma; Liam M Ashander; Milena Simões; Genevieve F Oliver; G Bracho Granado; Abby C Dawson; Michael Z Michael; Binoy Appukuttan; David J Lynn; Justine R Smith Journal: Front Immunol Date: 2021-04-22 Impact factor: 7.561
Authors: Rodolfo Mastropasqua; Emma Di Carlo; Carlo Sorrentino; Cesare Mariotti; Lyndon da Cruz Journal: J Clin Med Date: 2019-10-19 Impact factor: 4.241
Authors: Ian R Reekie; Srilakshmi Sharma; Andrew Foers; Jonathan Sherlock; Mark C Coles; Andrew D Dick; Alastair K Denniston; Christopher D Buckley Journal: Front Med (Lausanne) Date: 2021-10-29